Search all medical codes

Cyclosporine

CPT4 code

Name of the Procedure:

Cyclosporine Therapy
Common name(s): Cyclosporine, Neoral, Sandimmune

Summary

Cyclosporine is an immunosuppressive medication used to prevent organ transplant rejection and to treat certain autoimmune conditions. It suppresses the body's immune response, making it less likely to attack transplanted organs or overreact in autoimmune diseases.

Purpose

Medical Conditions Addressed:
  • Prevention of organ transplant rejection
  • Autoimmune diseases such as rheumatoid arthritis and psoriasis
Goals/Outcomes:
  • Protect a transplanted organ from the immune system's attack
  • Reduce immune system activity in autoimmune diseases to alleviate symptoms

Indications

  • Patients who have undergone organ transplantation (kidney, liver, heart, etc.)
  • Individuals diagnosed with severe rheumatoid arthritis or psoriasis not responding to other treatments

Preparation

  • Pre-procedure Instructions: Follow the doctor's advice on medication adjustments. Patients should avoid grapefruit or grapefruit juice as it can interfere with cyclosporine.
  • Diagnostic Tests: Regular blood tests to monitor kidney function, liver function, and cyclosporine levels.

Procedure Description

  • Step-by-Step:

    • The medication is administered orally in the form of a capsule or liquid, or intravenously.
    • Dosages are carefully determined based on individual patient needs and cyclosporine blood levels.
    • Regular blood tests are conducted to monitor and adjust the dosage.
  • Tools and Equipment: Oral capsules or liquid, intravenous administration setup if required.
  • Anesthesia/Sedation: Not applicable for oral or standard intravenous administration.

Duration

Cyclosporine therapy is ongoing and requires indefinite duration for organ transplant patients. Duration for autoimmune conditions varies based on patient response.

Setting

Typically administered at home after initial instruction, but can also be managed in a clinical setting, especially if intravenous administration is required.

Personnel

  • Healthcare Professionals Involved:
    • Prescribing Physician (e.g., transplant surgeon, rheumatologist)
    • Pharmacist
    • Nurse (for intravenous administration and patient education)

Risks and Complications

  • Common Risks:
    • Hypertension
    • Kidney dysfunction
    • Increased risk of infections
  • Rare Risks:
    • Lymphoma or other cancers due to immune suppression
    • Severe allergic reactions

Benefits

  • Expected Benefits:
    • Prevention of organ rejection in transplant patients
    • Symptom relief in autoimmune diseases
  • Timeline: Benefits generally begin within weeks but may vary by individual and condition treated.

Recovery

  • Post-Procedure Care:
    • Regular monitoring through blood tests
    • Compliance with medication schedule
  • Recovery Time: Continuous therapy with close monitoring; varies by condition.
  • Restrictions: Avoidance of certain foods and other medications that may interact with cyclosporine.

Alternatives

  • Other Treatment Options:
    • Other immunosuppressive drugs (e.g., tacrolimus)
    • Biologics for autoimmune diseases (e.g., TNF inhibitors)
  • Pros and Cons: Other drugs may have different side effect profiles or efficacy; choice depends on patient-specific factors and physician recommendation.

Patient Experience

  • During the Procedure:
    • Taking medication as prescribed; minimal discomfort if oral.
    • Regular blood draws for monitoring.
  • After the Procedure:
    • Possible side effects such as fatigue, gum overgrowth, and hand tremors.
    • Pain management as needed, especially during blood draws.

Overall, cyclosporine therapy requires diligent monitoring and adherence to medical advice to manage its benefits and risks effectively.